logo-loader
Circassia Pharmaceuticals PLC

Circassia hires Pfizer exec as it continues transition to commerical business

Circassia Pharmaceuticals PLC's (LON:CIR) CEO Steve Harris caught up with Proactive London's Andrew Scott after news they've hired one of Pfizer’s top executives to become its first chief operating officer.

Jonathan Emms, who has held a number of senior positions at both Pfizer and GlaxoSmithKline PLC (LON:GSK), will join the respiratory drug specialist next month.

Quick facts: Circassia Pharmaceuticals PLC

Price: £0.18

Market: LSE
Market Cap: £67.16 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Circassia Pharmaceuticals PLC named herein, including the promotion by the Company of Circassia Pharmaceuticals PLC in any Content on the Site,...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Circassia sets platform for strong growth in 2019 after period of consolidation

Steve Harris, chief executive of Circassia Pharmaceuticals PLC (LON:CIR), talks Proactive London's Andrew Scott through the group's 2018 results and the first quarter of this year. Circassia's taken full commercial control of Tudorza, a treatment for chronic obstructive pulmonary disease...

on 1/5/19

2 min read

;